The trajectory of companies tied to blockbuster drugs like Viagra presents a complex investment landscape . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the expiry in key regions has introduced substantial risk . Investors are now assessing the effect of generic competition , shr